Adaptimmune Therapeutics shares owned by Rock Springs Capital Management
Quarter-by-quarter ownership of Adaptimmune Therapeutics (ADAP) shares owned by Rock Springs Capital Management
from 13F filings
Historical chart of Rock Springs Capital Management investment in Adaptimmune Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Adaptimmune Therapeutics held by Rock Springs Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Adaptimmune Therapeutics by Rock Springs Capital Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-09-30 | $2.2M | 2.8M | 0.78 |
| 2023-06-30 | $2.6M | 2.8M | 0.93 |
| 2023-03-31 | $3.0M | 2.8M | 1.09 |
| 2022-12-31 | $3.9M | 2.7M | 1.46 |
| 2022-09-30 | $2.5M | 2.4M | 1.07 |
| 2022-06-30 | $4.0M | 2.4M | 1.70 |
| 2022-03-31 | $4.7M | 2.3M | 2.06 |
| 2021-12-31 | $8.3M | 2.2M | 3.75 |
| 2021-09-30 | $11M | 2.2M | 5.17 |
| 2021-06-30 | $6.6M | 1.5M | 4.26 |
| 2021-03-31 | $8.2M | 1.5M | 5.31 |
| 2020-12-31 | $8.3M | 1.5M | 5.39 |
| 2020-09-30 | $16M | 2.0M | 7.98 |
| 2020-06-30 | $20M | 2.0M | 10.01 |
| 2020-03-31 | $3.3M | 1.2M | 2.72 |
| 2019-12-31 | $960k | 800k | 1.20 |
| 2019-09-30 | $1.3M | 875k | 1.51 |
| 2019-06-30 | $3.5M | 875k | 4.02 |
| 2019-03-31 | $3.4M | 800k | 4.30 |
| 2018-12-31 | $4.3M | 750k | 5.75 |
| 2018-09-30 | $10M | 750k | 13.56 |
| 2018-06-30 | $8.9M | 750k | 11.87 |
| 2018-03-31 | $9.8M | 875k | 11.23 |
| 2017-12-31 | $5.8M | 875k | 6.68 |
| 2017-09-30 | $7.2M | 875k | 8.19 |
| 2017-06-30 | $3.9M | 875k | 4.49 |
| 2017-03-31 | $4.8M | 875k | 5.51 |
| 2016-12-31 | $2.7M | 675k | 4.05 |
| 2016-09-30 | $4.8M | 675k | 7.05 |
| 2016-06-30 | $6.2M | 765k | 8.15 |
| 2016-03-31 | $6.2M | 765k | 8.13 |
| 2015-12-31 | $9.2M | 765k | 12.06 |
| 2015-09-30 | $9.1M | 756k | 11.97 |
| 2015-06-30 | $17M | 905k | 18.33 |
More positions owned by Rock Springs Capital Management
View all positions for Rock Springs Capital Management